Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites
Clinical trial NCT03168854 · COMPLETED
Trial details
- NCT number
- NCT03168854
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2019-08-16
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.